论文部分内容阅读
急性缺血性脑卒中(AIS)患者的血压(BP)普遍升高[Arch Neurol,2008,65(9):1174-1178]。指南建议:应该采取积极措施,如持续注射盐酸尼卡地平,使BP185/110mmHg,方可用组织型纤溶酶原激活酶(tPA)进行溶栓治疗。该文评价BP升高后和降压治疗对tPA治疗AIS的临床预后的影响。评估AIS患
Blood pressure (BP) is generally elevated in patients with acute ischemic stroke (AIS) [Arch Neurol, 2008, 65 (9): 1174-1178]. The guidelines suggest that aggressive measures such as sustained-dose nicardipine hydrochloride and BP185 / 110 mmHg should be used before thrombolytic therapy with tissue-type plasminogen activator (tPA). This article evaluates the effects of BP elevation and antihypertensive therapy on the clinical outcome of tPA in the treatment of AIS. Assess AIS